University Clinical Centre of Kosova   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Pristina Kosovo (1958)

Organization Overview

First Clinical Trial
2010
NCT01342835
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Rajmonda Nallbani-Komoni | University Clinical Centre of Kosova

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Jaundice (Phase 2)

Jaundice, Obstructive (Phase 2)

Pain, Postoperative (Phase 2)

Substance-Related Disorders (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 10